Finance

Lists
C1S:FRA
China Shineway Pharmaceutical Group Ltd
€0.90
+2.86%
(+0.025) 1D
Sep 8, 8:55:02 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for C1S...
Open
€0.90
High
€0.90
Low
€0.90
Mkt. cap
6.95B
Avg. vol.
0.00
Volume
0.00
52-wk high
€1.10
52-wk low
€0.80
No. of employees
3K
Open
€0.90
High
€0.90
Low
€0.90
Mkt. cap
6.95B
Avg. vol.
0.00
Volume
0.00
52-wk high
€1.10
52-wk low
€0.80
No. of employees
3K
News stories
From web sources and news partners
About China Shineway Pharmaceutical Group Ltd
CEO-
Employees2.82K
Founded2002
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
741.36M
741.36M
590.54M
590.54M
Cost of goods sold
205.06M
205.06M
177.73M
177.73M
Cost of revenue
205.06M
205.06M
177.73M
177.73M
Research and development expenses
26.36M
26.36M
33.48M
33.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
335.51M
335.51M
209.54M
209.54M
Operating expense
380.65M
380.65M
243.04M
243.04M
Total operating expenses
585.71M
585.71M
420.77M
420.77M
Operating income
155.65M
155.65M
169.77M
169.77M
Other non operating income
6.28M
6.28M
59.00M
59.00M
EBT including unusual items
247.29M
247.29M
284.15M
284.15M
EBT excluding unusual items
248.69M
248.69M
284.15M
284.15M
Income tax expense
79.65M
79.65M
49.58M
49.58M
Effective tax rate
32.21%
32.21%
17.45%
17.45%
Other operating expenses
-
-
-
-
Net income
167.64M
167.64M
234.58M
234.58M
Net profit margin
22.61%
22.61%
39.72%
39.72%
Earnings per share
-
-
-
-
Interest and investment income
87.60M
87.60M
56.49M
56.49M
Interest expense
-
-
-1.11M
-1.11M
Net interest expenses
87.60M
87.60M
55.39M
55.39M
Depreciation and amortization charges
-
-
-
-
EBITDA
177.54M
170.01M
184.13M
184.13M
Gain or loss from assets sale
-2.42M
-2.42M
-
-
AI content may include mistakes. Learn more
Google apps